Global Immune in Vitro Diagnostics Market Growth (Status and Outlook) 2024-2030

The Immune in Vitro Diagnostics market is projected to grow from USD 22.87 Billion in 2023 to USD 37.01 Billion in 2030, driven by the increasing need for accurate and fast diagnos

Immune in vitro diagnostics (IVD) involve the examination of components related to the immune system, often using laboratory tests performed on biological samples taken from the human body. These tests play a crucial role in understanding the immune response, diagnosing immunological disorders, monitoring the effectiveness of treatments, and assessing overall immune health. The global Immune in Vitro Diagnostics market size is projected to grow from US$ 22870 million in 2023 to US$ 37010 million in 2030; it is expected to grow at a CAGR of 7.1% from 2024 to 2030. Our publisher’s newest research report, the “Immune in Vitro Diagnostics Industry Forecast” looks at past sales and reviews total world Immune in Vitro Diagnostics sales in 2023, providing a comprehensive analysis by region and market sector of projected Immune in Vitro Diagnostics sales for 2024 through 2030. With Immune in Vitro Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immune in Vitro Diagnostics industry. This Insight Report provides a comprehensive analysis of the global Immune in Vitro Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immune in Vitro Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immune in Vitro Diagnostics market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immune in Vitro Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immune in Vitro Diagnostics. The Immune In Vitro Diagnostics market is propelled by a growing demand for advanced diagnostic tools to assess the immune system's functionality and response. With the increasing incidence of immune-related disorders, including autoimmune diseases and allergies, there is a heightened need for accurate and timely diagnostics. Immune in vitro diagnostic devices, such as immunoassays, flow cytometry, and molecular diagnostics, play a crucial role in evaluating immune biomarkers. The market is driven by ongoing research in immunology, leading to the development of more specific and sensitive diagnostic technologies. Additionally, a focus on personalized medicine and treatment strategies contributes to the continuous evolution and adoption of immune in vitro diagnostics in clinical practice. Market Drivers and Challenges: The global immune in vitro diagnostics market is expected to experience significant growth due to several market drivers and challenges.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Market Drivers: Increased investment in research and development in genomics and proteomics: The growing demand for personalized medicine and the need for accurate diagnostic tests are driving the growth of the immune in vitro diagnostics market. Rising prevalence of autoimmune diseases: The increasing incidence of autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis is driving the demand for immune in vitro diagnostics tests. Advances in technology: Advances in technologies such as molecular diagnostics, immunoassays, and flow cytometry are enabling the development of more accurate and efficient diagnostic tests. Growing demand for point-of-care testing: The need for rapid and convenient diagnostic testing is driving the demand for point-of-care testing, which is a key segment of the immune in vitro diagnostics market. Increasing awareness of infectious diseases: The growing awareness of infectious diseases such as COVID-19, HIV, and tuberculosis is driving the demand for diagnostic tests that can quickly and accurately identify these diseases. Market Challenges: Regulatory framework: The regulatory framework for immune in vitro diagnostics is complex and varies by region, which can create challenges for manufacturers and healthcare providers. Reimbursement issues: Reimbursement for immune in vitro diagnostics tests can be a challenge, particularly in regions with limited healthcare resources. High cost of testing: The cost of immune in vitro diagnostics tests can be high, which can limit access to these tests, particularly in low- and middle-income countries. Limited availability of skilled professionals: The availability of skilled professionals, such as laboratory technicians and pathologists, can be limited in some regions, which can create challenges for the implementation of immune in vitro diagnostics tests. Competition from low-cost providers: The immune in vitro diagnostics market is highly competitive, and the entry of low-cost providers can create challenges for established manufacturers. Technological Development: The global immune in vitro diagnostics (IVD) market is witnessing significant technological advancements, driven by the increasing demand for accurate and rapid diagnostic tests. The market is expected to grow at a CAGR of 5.20% from 2024 to 2029, reaching a value of USD 131.66 billion by 2029. Recent Developments: Molecular Diagnostics: Molecular diagnostics is a rapidly growing segment in the IVD market, driven by the increasing adoption of next-generation sequencing (NGS) and digital PCR technologies. These technologies enable the detection of genetic mutations and biomarkers, allowing for more accurate and personalized diagnosis. Point-of-Care (POC) Testing: POC testing is gaining popularity due to its ability to provide rapid and accurate results at the point of care, reducing the need for laboratory testing and improving patient outcomes. Artificial Intelligence (AI) and Machine Learning (ML): AI and ML are being increasingly used in IVD to improve the accuracy and efficiency of diagnostic tests. These technologies enable the analysis of large datasets and the identification of patterns and trends, allowing for more accurate diagnosis and treatment. Liquid Biopsy: Liquid biopsy is a non-invasive diagnostic test that involves analyzing circulating tumor cells or DNA in the blood or other bodily fluids. This technology has the potential to revolutionize cancer diagnosis and treatment. Microfluidics: Microfluidics is a technology that enables the manipulation of small volumes of fluids and is being used in IVD to develop portable and cost-effective diagnostic devices. Recommendations and Opportunities: The global immune in vitro diagnostics (IVD) market is expected to grow at a CAGR of 4.4% from 2024 to 2030, driven by the increasing demand for diagnostic tests, advancements in technology, and the growing need for personalized medicine. Here are some recommendations and opportunities in the global immune IVD market: Recommendations: Invest in Molecular Diagnostics: Molecular diagnostics is a rapidly growing segment in the IVD market, driven by the increasing demand for accurate and rapid diagnosis of infectious diseases. Companies should invest in developing and commercializing molecular diagnostic tests for various applications. Focus on Point-of-Care (POC) Diagnostics: POC diagnostics is a growing trend in the IVD market, driven by the need for rapid and convenient testing. Companies should focus on developing POC diagnostic tests for various applications, including infectious diseases and chronic diseases. Develop Immunoassays for Infectious Diseases: Immunoassays are a widely used diagnostic technique in the IVD market. Companies should focus on developing immunoassays for infectious diseases, such as HIV, hepatitis, and tuberculosis, to cater to the growing demand for diagnostic tests. Invest in Automation and Robotics: Automation and robotics are becoming increasingly important in the IVD market, driven by the need for increased efficiency and reduced costs. Companies should invest in automation and robotics technologies to improve their diagnostic capabilities and reduce costs. Focus on Companion Diagnostics: Companion diagnostics are diagnostic tests that are used to identify patients who are likely to respond to a particular treatment. Companies should focus on developing companion diagnostics for various applications, including oncology and infectious diseases. Opportunities: Growing Demand for Diagnostic Tests: The global IVD market is expected to grow at a CAGR of 4.4% from 2024 to 2030, driven by the increasing demand for diagnostic tests. Companies should capitalize on this growth opportunity by developing and commercializing new diagnostic tests. Advancements in Technology: Advances in technology, such as automation and robotics, are driving innovation in the IVD market. Companies should invest in these technologies to improve their diagnostic capabilities and reduce costs. Growing Need for Personalized Medicine: The growing need for personalized medicine is driving the demand for diagnostic tests that can identify patients who are likely to respond to a particular treatment. Companies should focus on developing companion diagnostics for various applications, including oncology and infectious diseases. Increasing Funding for Research and Development: Governments and private organizations are increasing funding for research and development in the IVD market, driven by the growing need for innovative diagnostic tests. Companies should capitalize on this funding opportunity by investing in research and development. Growing Demand for POC Diagnostics: POC diagnostics is a growing trend in the IVD market, driven by the need for rapid and convenient testing. Companies should focus on developing POC diagnostic tests for various applications, including infectious diseases and chronic diseases. This report presents a comprehensive overview, market shares, and growth opportunities of Immune in Vitro Diagnostics market by product type, application, key players and key regions and countries. Segmentation by type Consumables Equipment Segmentation by application Hepatitis Test STD Testing Tumor Detection Other This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Roche Siemens Abbott Danaher Thermo Fisher BioMerieux Bio-Rad BD KHB Daan Gene Leadman Zhongsheng Bsbe Maccura Hitachi Canon Sysmex Auto Bio Mindray Bgi Wondfo

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Immune in Vitro Diagnostics Market Size 2019-2030
  • 2.1.2 Immune in Vitro Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
  • 2.2 Immune in Vitro Diagnostics Segment by Type
  • 2.2.1 Consumables
  • 2.2.2 Equipment
  • 2.3 Immune in Vitro Diagnostics Market Size by Type
  • 2.3.1 Immune in Vitro Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
  • 2.3.2 Global Immune in Vitro Diagnostics Market Size Market Share by Type (2019-2024)
  • 2.4 Immune in Vitro Diagnostics Segment by Application
  • 2.4.1 Hepatitis Test
  • 2.4.2 STD Testing
  • 2.4.3 Tumor Detection
  • 2.4.4 Other
  • 2.5 Immune in Vitro Diagnostics Market Size by Application
  • 2.5.1 Immune in Vitro Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
  • 2.5.2 Global Immune in Vitro Diagnostics Market Size Market Share by Application (2019-2024)
  • 3 Immune in Vitro Diagnostics Market Size by Player
  • 3.1 Immune in Vitro Diagnostics Market Size Market Share by Players
  • 3.1.1 Global Immune in Vitro Diagnostics Revenue by Players (2019-2024)
  • 3.1.2 Global Immune in Vitro Diagnostics Revenue Market Share by Players (2019-2024)
  • 3.2 Global Immune in Vitro Diagnostics Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion
  • 4 Immune in Vitro Diagnostics by Regions
  • 4.1 Immune in Vitro Diagnostics Market Size by Regions (2019-2024)
  • 4.2 Americas Immune in Vitro Diagnostics Market Size Growth (2019-2024)
  • 4.3 APAC Immune in Vitro Diagnostics Market Size Growth (2019-2024)
  • 4.4 Europe Immune in Vitro Diagnostics Market Size Growth (2019-2024)
  • 4.5 Middle East & Africa Immune in Vitro Diagnostics Market Size Growth (2019-2024)
  • 5 Americas
  • 5.1 Americas Immune in Vitro Diagnostics Market Size by Country (2019-2024)
  • 5.2 Americas Immune in Vitro Diagnostics Market Size by Type (2019-2024)
  • 5.3 Americas Immune in Vitro Diagnostics Market Size by Application (2019-2024)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Immune in Vitro Diagnostics Market Size by Region (2019-2024)
  • 6.2 APAC Immune in Vitro Diagnostics Market Size by Type (2019-2024)
  • 6.3 APAC Immune in Vitro Diagnostics Market Size by Application (2019-2024)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 7 Europe
  • 7.1 Europe Immune in Vitro Diagnostics by Country (2019-2024)
  • 7.2 Europe Immune in Vitro Diagnostics Market Size by Type (2019-2024)
  • 7.3 Europe Immune in Vitro Diagnostics Market Size by Application (2019-2024)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Immune in Vitro Diagnostics by Region (2019-2024)
  • 8.2 Middle East & Africa Immune in Vitro Diagnostics Market Size by Type (2019-2024)
  • 8.3 Middle East & Africa Immune in Vitro Diagnostics Market Size by Application (2019-2024)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Global Immune in Vitro Diagnostics Market Forecast
  • 10.1 Global Immune in Vitro Diagnostics Forecast by Regions (2025-2030)
  • 10.1.1 Global Immune in Vitro Diagnostics Forecast by Regions (2025-2030)
  • 10.1.2 Americas Immune in Vitro Diagnostics Forecast
  • 10.1.3 APAC Immune in Vitro Diagnostics Forecast
  • 10.1.4 Europe Immune in Vitro Diagnostics Forecast
  • 10.1.5 Middle East & Africa Immune in Vitro Diagnostics Forecast
  • 10.2 Americas Immune in Vitro Diagnostics Forecast by Country (2025-2030)
  • 10.2.1 United States Immune in Vitro Diagnostics Market Forecast
  • 10.2.2 Canada Immune in Vitro Diagnostics Market Forecast
  • 10.2.3 Mexico Immune in Vitro Diagnostics Market Forecast
  • 10.2.4 Brazil Immune in Vitro Diagnostics Market Forecast
  • 10.3 APAC Immune in Vitro Diagnostics Forecast by Region (2025-2030)
  • 10.3.1 China Immune in Vitro Diagnostics Market Forecast
  • 10.3.2 Japan Immune in Vitro Diagnostics Market Forecast
  • 10.3.3 Korea Immune in Vitro Diagnostics Market Forecast
  • 10.3.4 Southeast Asia Immune in Vitro Diagnostics Market Forecast
  • 10.3.5 India Immune in Vitro Diagnostics Market Forecast
  • 10.3.6 Australia Immune in Vitro Diagnostics Market Forecast
  • 10.4 Europe Immune in Vitro Diagnostics Forecast by Country (2025-2030)
  • 10.4.1 Germany Immune in Vitro Diagnostics Market Forecast
  • 10.4.2 France Immune in Vitro Diagnostics Market Forecast
  • 10.4.3 UK Immune in Vitro Diagnostics Market Forecast
  • 10.4.4 Italy Immune in Vitro Diagnostics Market Forecast
  • 10.4.5 Russia Immune in Vitro Diagnostics Market Forecast
  • 10.5 Middle East & Africa Immune in Vitro Diagnostics Forecast by Region (2025-2030)
  • 10.5.1 Egypt Immune in Vitro Diagnostics Market Forecast
  • 10.5.2 South Africa Immune in Vitro Diagnostics Market Forecast
  • 10.5.3 Israel Immune in Vitro Diagnostics Market Forecast
  • 10.5.4 Turkey Immune in Vitro Diagnostics Market Forecast
  • 10.5.5 GCC Countries Immune in Vitro Diagnostics Market Forecast
  • 10.6 Global Immune in Vitro Diagnostics Forecast by Type (2025-2030)
  • 10.7 Global Immune in Vitro Diagnostics Forecast by Application (2025-2030)
  • 11 Key Players Analysis
  • 11.1 Roche
  • 11.1.1 Roche Company Information
  • 11.1.2 Roche Immune in Vitro Diagnostics Product Offered
  • 11.1.3 Roche Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.1.4 Roche Main Business Overview
  • 11.1.5 Roche Latest Developments
  • 11.2 Siemens
  • 11.2.1 Siemens Company Information
  • 11.2.2 Siemens Immune in Vitro Diagnostics Product Offered
  • 11.2.3 Siemens Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.2.4 Siemens Main Business Overview
  • 11.2.5 Siemens Latest Developments
  • 11.3 Abbott
  • 11.3.1 Abbott Company Information
  • 11.3.2 Abbott Immune in Vitro Diagnostics Product Offered
  • 11.3.3 Abbott Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.3.4 Abbott Main Business Overview
  • 11.3.5 Abbott Latest Developments
  • 11.4 Danaher
  • 11.4.1 Danaher Company Information
  • 11.4.2 Danaher Immune in Vitro Diagnostics Product Offered
  • 11.4.3 Danaher Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.4.4 Danaher Main Business Overview
  • 11.4.5 Danaher Latest Developments
  • 11.5 Thermo Fisher
  • 11.5.1 Thermo Fisher Company Information
  • 11.5.2 Thermo Fisher Immune in Vitro Diagnostics Product Offered
  • 11.5.3 Thermo Fisher Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.5.4 Thermo Fisher Main Business Overview
  • 11.5.5 Thermo Fisher Latest Developments
  • 11.6 BioMerieux
  • 11.6.1 BioMerieux Company Information
  • 11.6.2 BioMerieux Immune in Vitro Diagnostics Product Offered
  • 11.6.3 BioMerieux Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.6.4 BioMerieux Main Business Overview
  • 11.6.5 BioMerieux Latest Developments
  • 11.7 Bio-Rad
  • 11.7.1 Bio-Rad Company Information
  • 11.7.2 Bio-Rad Immune in Vitro Diagnostics Product Offered
  • 11.7.3 Bio-Rad Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.7.4 Bio-Rad Main Business Overview
  • 11.7.5 Bio-Rad Latest Developments
  • 11.8 BD
  • 11.8.1 BD Company Information
  • 11.8.2 BD Immune in Vitro Diagnostics Product Offered
  • 11.8.3 BD Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.8.4 BD Main Business Overview
  • 11.8.5 BD Latest Developments
  • 11.9 KHB
  • 11.9.1 KHB Company Information
  • 11.9.2 KHB Immune in Vitro Diagnostics Product Offered
  • 11.9.3 KHB Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.9.4 KHB Main Business Overview
  • 11.9.5 KHB Latest Developments
  • 11.10 Daan Gene
  • 11.10.1 Daan Gene Company Information
  • 11.10.2 Daan Gene Immune in Vitro Diagnostics Product Offered
  • 11.10.3 Daan Gene Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.10.4 Daan Gene Main Business Overview
  • 11.10.5 Daan Gene Latest Developments
  • 11.11 Leadman
  • 11.11.1 Leadman Company Information
  • 11.11.2 Leadman Immune in Vitro Diagnostics Product Offered
  • 11.11.3 Leadman Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.11.4 Leadman Main Business Overview
  • 11.11.5 Leadman Latest Developments
  • 11.12 Zhongsheng
  • 11.12.1 Zhongsheng Company Information
  • 11.12.2 Zhongsheng Immune in Vitro Diagnostics Product Offered
  • 11.12.3 Zhongsheng Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.12.4 Zhongsheng Main Business Overview
  • 11.12.5 Zhongsheng Latest Developments
  • 11.13 Bsbe
  • 11.13.1 Bsbe Company Information
  • 11.13.2 Bsbe Immune in Vitro Diagnostics Product Offered
  • 11.13.3 Bsbe Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.13.4 Bsbe Main Business Overview
  • 11.13.5 Bsbe Latest Developments
  • 11.14 Maccura
  • 11.14.1 Maccura Company Information
  • 11.14.2 Maccura Immune in Vitro Diagnostics Product Offered
  • 11.14.3 Maccura Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.14.4 Maccura Main Business Overview
  • 11.14.5 Maccura Latest Developments
  • 11.15 Hitachi
  • 11.15.1 Hitachi Company Information
  • 11.15.2 Hitachi Immune in Vitro Diagnostics Product Offered
  • 11.15.3 Hitachi Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.15.4 Hitachi Main Business Overview
  • 11.15.5 Hitachi Latest Developments
  • 11.16 Canon
  • 11.16.1 Canon Company Information
  • 11.16.2 Canon Immune in Vitro Diagnostics Product Offered
  • 11.16.3 Canon Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.16.4 Canon Main Business Overview
  • 11.16.5 Canon Latest Developments
  • 11.17 Sysmex
  • 11.17.1 Sysmex Company Information
  • 11.17.2 Sysmex Immune in Vitro Diagnostics Product Offered
  • 11.17.3 Sysmex Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.17.4 Sysmex Main Business Overview
  • 11.17.5 Sysmex Latest Developments
  • 11.18 Auto Bio
  • 11.18.1 Auto Bio Company Information
  • 11.18.2 Auto Bio Immune in Vitro Diagnostics Product Offered
  • 11.18.3 Auto Bio Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.18.4 Auto Bio Main Business Overview
  • 11.18.5 Auto Bio Latest Developments
  • 11.19 Mindray
  • 11.19.1 Mindray Company Information
  • 11.19.2 Mindray Immune in Vitro Diagnostics Product Offered
  • 11.19.3 Mindray Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.19.4 Mindray Main Business Overview
  • 11.19.5 Mindray Latest Developments
  • 11.20 Bgi
  • 11.20.1 Bgi Company Information
  • 11.20.2 Bgi Immune in Vitro Diagnostics Product Offered
  • 11.20.3 Bgi Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.20.4 Bgi Main Business Overview
  • 11.20.5 Bgi Latest Developments
  • 11.21 Wondfo
  • 11.21.1 Wondfo Company Information
  • 11.21.2 Wondfo Immune in Vitro Diagnostics Product Offered
  • 11.21.3 Wondfo Immune in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.21.4 Wondfo Main Business Overview
  • 11.21.5 Wondfo Latest Developments
  • 12 Research Findings and Conclusion

Table 1. Immune in Vitro Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions) Table 2. Major Players of Consumables Table 3. Major Players of Equipment Table 4. Immune in Vitro Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions) Table 5. Global Immune in Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions) Table 6. Global Immune in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Table 7. Immune in Vitro Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions) Table 8. Global Immune in Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions) Table 9. Global Immune in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Table 10. Global Immune in Vitro Diagnostics Revenue by Players (2019-2024) & ($ Millions) Table 11. Global Immune in Vitro Diagnostics Revenue Market Share by Player (2019-2024) Table 12. Immune in Vitro Diagnostics Key Players Head office and Products Offered Table 13. Immune in Vitro Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Immune in Vitro Diagnostics Market Size by Regions 2019-2024 & ($ Millions) Table 17. Global Immune in Vitro Diagnostics Market Size Market Share by Regions (2019-2024) Table 18. Global Immune in Vitro Diagnostics Revenue by Country/Region (2019-2024) & ($ millions) Table 19. Global Immune in Vitro Diagnostics Revenue Market Share by Country/Region (2019-2024) Table 20. Americas Immune in Vitro Diagnostics Market Size by Country (2019-2024) & ($ Millions) Table 21. Americas Immune in Vitro Diagnostics Market Size Market Share by Country (2019-2024) Table 22. Americas Immune in Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions) Table 23. Americas Immune in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Table 24. Americas Immune in Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions) Table 25. Americas Immune in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Table 26. APAC Immune in Vitro Diagnostics Market Size by Region (2019-2024) & ($ Millions) Table 27. APAC Immune in Vitro Diagnostics Market Size Market Share by Region (2019-2024) Table 28. APAC Immune in Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions) Table 29. APAC Immune in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Table 30. APAC Immune in Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions) Table 31. APAC Immune in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Table 32. Europe Immune in Vitro Diagnostics Market Size by Country (2019-2024) & ($ Millions) Table 33. Europe Immune in Vitro Diagnostics Market Size Market Share by Country (2019-2024) Table 34. Europe Immune in Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions) Table 35. Europe Immune in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Table 36. Europe Immune in Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions) Table 37. Europe Immune in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Table 38. Middle East & Africa Immune in Vitro Diagnostics Market Size by Region (2019-2024) & ($ Millions) Table 39. Middle East & Africa Immune in Vitro Diagnostics Market Size Market Share by Region (2019-2024) Table 40. Middle East & Africa Immune in Vitro Diagnostics Market Size by Type (2019-2024) & ($ Millions) Table 41. Middle East & Africa Immune in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Table 42. Middle East & Africa Immune in Vitro Diagnostics Market Size by Application (2019-2024) & ($ Millions) Table 43. Middle East & Africa Immune in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Table 44. Key Market Drivers & Growth Opportunities of Immune in Vitro Diagnostics Table 45. Key Market Challenges & Risks of Immune in Vitro Diagnostics Table 46. Key Industry Trends of Immune in Vitro Diagnostics Table 47. Global Immune in Vitro Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions) Table 48. Global Immune in Vitro Diagnostics Market Size Market Share Forecast by Regions (2025-2030) Table 49. Global Immune in Vitro Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions) Table 50. Global Immune in Vitro Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions) Table 51. Roche Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 52. Roche Immune in Vitro Diagnostics Product Offered Table 53. Roche Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 54. Roche Main Business Table 55. Roche Latest Developments Table 56. Siemens Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 57. Siemens Immune in Vitro Diagnostics Product Offered Table 58. Siemens Main Business Table 59. Siemens Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 60. Siemens Latest Developments Table 61. Abbott Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 62. Abbott Immune in Vitro Diagnostics Product Offered Table 63. Abbott Main Business Table 64. Abbott Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 65. Abbott Latest Developments Table 66. Danaher Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 67. Danaher Immune in Vitro Diagnostics Product Offered Table 68. Danaher Main Business Table 69. Danaher Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 70. Danaher Latest Developments Table 71. Thermo Fisher Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 72. Thermo Fisher Immune in Vitro Diagnostics Product Offered Table 73. Thermo Fisher Main Business Table 74. Thermo Fisher Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 75. Thermo Fisher Latest Developments Table 76. BioMerieux Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 77. BioMerieux Immune in Vitro Diagnostics Product Offered Table 78. BioMerieux Main Business Table 79. BioMerieux Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 80. BioMerieux Latest Developments Table 81. Bio-Rad Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 82. Bio-Rad Immune in Vitro Diagnostics Product Offered Table 83. Bio-Rad Main Business Table 84. Bio-Rad Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 85. Bio-Rad Latest Developments Table 86. BD Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 87. BD Immune in Vitro Diagnostics Product Offered Table 88. BD Main Business Table 89. BD Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 90. BD Latest Developments Table 91. KHB Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 92. KHB Immune in Vitro Diagnostics Product Offered Table 93. KHB Main Business Table 94. KHB Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 95. KHB Latest Developments Table 96. Daan Gene Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 97. Daan Gene Immune in Vitro Diagnostics Product Offered Table 98. Daan Gene Main Business Table 99. Daan Gene Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 100. Daan Gene Latest Developments Table 101. Leadman Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 102. Leadman Immune in Vitro Diagnostics Product Offered Table 103. Leadman Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 104. Leadman Main Business Table 105. Leadman Latest Developments Table 106. Zhongsheng Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 107. Zhongsheng Immune in Vitro Diagnostics Product Offered Table 108. Zhongsheng Main Business Table 109. Zhongsheng Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 110. Zhongsheng Latest Developments Table 111. Bsbe Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 112. Bsbe Immune in Vitro Diagnostics Product Offered Table 113. Bsbe Main Business Table 114. Bsbe Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 115. Bsbe Latest Developments Table 116. Maccura Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 117. Maccura Immune in Vitro Diagnostics Product Offered Table 118. Maccura Main Business Table 119. Maccura Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 120. Maccura Latest Developments Table 121. Hitachi Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 122. Hitachi Immune in Vitro Diagnostics Product Offered Table 123. Hitachi Main Business Table 124. Hitachi Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 125. Hitachi Latest Developments Table 126. Canon Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 127. Canon Immune in Vitro Diagnostics Product Offered Table 128. Canon Main Business Table 129. Canon Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 130. Canon Latest Developments Table 131. Sysmex Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 132. Sysmex Immune in Vitro Diagnostics Product Offered Table 133. Sysmex Main Business Table 134. Sysmex Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 135. Sysmex Latest Developments Table 136. Auto Bio Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 137. Auto Bio Immune in Vitro Diagnostics Product Offered Table 138. Auto Bio Main Business Table 139. Auto Bio Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 140. Auto Bio Latest Developments Table 141. Mindray Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 142. Mindray Immune in Vitro Diagnostics Product Offered Table 143. Mindray Main Business Table 144. Mindray Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 145. Mindray Latest Developments Table 146. Bgi Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 147. Bgi Immune in Vitro Diagnostics Product Offered Table 148. Bgi Main Business Table 149. Bgi Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 150. Bgi Latest Developments Table 151. Wondfo Details, Company Type, Immune in Vitro Diagnostics Area Served and Its Competitors Table 152. Wondfo Immune in Vitro Diagnostics Product Offered Table 153. Wondfo Immune in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 154. Wondfo Main Business Table 155. Wondfo Latest Developments

Figure 1. Immune in Vitro Diagnostics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Immune in Vitro Diagnostics Market Size Growth Rate 2019-2030 ($ Millions) Figure 6. Immune in Vitro Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Immune in Vitro Diagnostics Sales Market Share by Country/Region (2023) Figure 8. Immune in Vitro Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Immune in Vitro Diagnostics Market Size Market Share by Type in 2023 Figure 10. Immune in Vitro Diagnostics in Hepatitis Test Figure 11. Global Immune in Vitro Diagnostics Market: Hepatitis Test (2019-2024) & ($ Millions) Figure 12. Immune in Vitro Diagnostics in STD Testing Figure 13. Global Immune in Vitro Diagnostics Market: STD Testing (2019-2024) & ($ Millions) Figure 14. Immune in Vitro Diagnostics in Tumor Detection Figure 15. Global Immune in Vitro Diagnostics Market: Tumor Detection (2019-2024) & ($ Millions) Figure 16. Immune in Vitro Diagnostics in Other Figure 17. Global Immune in Vitro Diagnostics Market: Other (2019-2024) & ($ Millions) Figure 18. Global Immune in Vitro Diagnostics Market Size Market Share by Application in 2023 Figure 19. Global Immune in Vitro Diagnostics Revenue Market Share by Player in 2023 Figure 20. Global Immune in Vitro Diagnostics Market Size Market Share by Regions (2019-2024) Figure 21. Americas Immune in Vitro Diagnostics Market Size 2019-2024 ($ Millions) Figure 22. APAC Immune in Vitro Diagnostics Market Size 2019-2024 ($ Millions) Figure 23. Europe Immune in Vitro Diagnostics Market Size 2019-2024 ($ Millions) Figure 24. Middle East & Africa Immune in Vitro Diagnostics Market Size 2019-2024 ($ Millions) Figure 25. Americas Immune in Vitro Diagnostics Value Market Share by Country in 2023 Figure 26. United States Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 27. Canada Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 28. Mexico Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 29. Brazil Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 30. APAC Immune in Vitro Diagnostics Market Size Market Share by Region in 2023 Figure 31. APAC Immune in Vitro Diagnostics Market Size Market Share by Type in 2023 Figure 32. APAC Immune in Vitro Diagnostics Market Size Market Share by Application in 2023 Figure 33. China Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 34. Japan Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 35. Korea Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 36. Southeast Asia Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 37. India Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 38. Australia Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 39. Europe Immune in Vitro Diagnostics Market Size Market Share by Country in 2023 Figure 40. Europe Immune in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Figure 41. Europe Immune in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Figure 42. Germany Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 43. France Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 44. UK Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 45. Italy Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 46. Russia Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 47. Middle East & Africa Immune in Vitro Diagnostics Market Size Market Share by Region (2019-2024) Figure 48. Middle East & Africa Immune in Vitro Diagnostics Market Size Market Share by Type (2019-2024) Figure 49. Middle East & Africa Immune in Vitro Diagnostics Market Size Market Share by Application (2019-2024) Figure 50. Egypt Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 51. South Africa Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 52. Israel Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 53. Turkey Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 54. GCC Country Immune in Vitro Diagnostics Market Size Growth 2019-2024 ($ Millions) Figure 55. Americas Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 56. APAC Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 57. Europe Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 58. Middle East & Africa Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 59. United States Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 60. Canada Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 61. Mexico Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 62. Brazil Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 63. China Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 64. Japan Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 65. Korea Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 66. Southeast Asia Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 67. India Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 68. Australia Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 69. Germany Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 70. France Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 71. UK Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 72. Italy Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 73. Russia Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 74. Spain Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 75. Egypt Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 76. South Africa Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 77. Israel Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 78. Turkey Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 79. GCC Countries Immune in Vitro Diagnostics Market Size 2025-2030 ($ Millions) Figure 80. Global Immune in Vitro Diagnostics Market Size Market Share Forecast by Type (2025-2030) Figure 81. Global Immune in Vitro Diagnostics Market Size Market Share Forecast by Application (2025-2030)
Logo

Global Immune in Vitro Diagnostics Market Growth (Status and Outlook) 2024-2030

Contact usWe are friendly and approachable, give us a call.